Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain further information on the tolerability and efficacy of Atrovent® inhaletten® in
the treatment of chronic obstructive airways disease under conditions of daily practice